White Papers

Beyond Immune Checkpoint Inhibitors to a New Era of Personalized Medicine: Planning and Conducting Trials of the Latest Immunotherapies (487.2 KB)
Clinical Monitoring Challenges in Human Abuse Liability Studies (623.51 KB)
Considerations When Selecting A CRO For Phase I Clinical Studies (197 KB)
Critical Success Factors For Clinical Trials Of Immune Checkpoint Inhibitors (112.47 KB)
e-Recruiting: Using Digital Platforms, Social Media, and Mobile Technologies to Improve Clinical Trial Enrollment (4.36 MB)
Elderly Representation in Clinical Trials: Not a Gray Area (747.97 KB)
Financial Conflicts of Interest In U.S. Public Health Service Funded Research (70.23 KB)
Forecasting Trial Enrollment: More Data, Better Analytics, Greater Predictability (5.41 MB)
Managing Clinical Trial Risk: It's a Tough Job, But One Person Has To Do It (707.99 KB)
Pharmacometrics: A Competitive Advantage in Improving R&D for Companies of All Sizes (1.01 MB)
Preferred Relationships Between CROs and Investigators: A Proactive Approach to Speeding Patient Enrollment (379.67 KB)
Pursuing Accelerated Approval in Oncology Indications: Regulatory, Medical and Logistical Considerations (304.88 KB)
Talent Management Solutions To The CRA Shortage: Investing In A Global Talent Pool (148.46 KB)
Taking Strategic Partnerships to the Next Level (867.88 KB)
Taking The Guesswork Out Of Feasibility Assessment In Oncology Trials (177.58 KB)
Unblinded Monitoring in HCV Trials (85.18 KB)
Understanding the Continuum of Clinical Collaboration: Maximizing Partner Relationships and Unlocking Greater Value (547.24 KB)
Upping their Game: CROs Must Develop a New Mindset to Partner with Sponsors (576.67 KB)